⌘K
Loading ticker…
As of 2026-08-24, UroGen Pharma Ltd. Ordinary Shares (URGN) has a 3-month relative strength percentile of 95 and a leadership percentile of 98 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 77. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.3%, relative volume 0.84×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
URGN is in a stage 2 uptrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 13.7% / 69.0%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
URGN is held by 12 ETFs as of May 2026. Top owner: VTWO at 0.03% weight, $6M notional. Top 3 carry $10M.
Held by 13 ETFs · $12M across latest filings · largest weight 0.32% (ACSG).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $106K |
| — |
| VTHRVanguard Russell 3000 ETF | 0.00% | $98K | — |
| IBBQ | 0.10% | $71K | +0.03 pp |
| WSML | 0.01% | $67K | new |
| ACSG | 0.32% | $56K | +0.02 pp |
Showing 10 of 12 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | URGN Jan avg: 2.23% median: 4.02% win: 75% σ: 13.80% n: 4 2022-04-12 → 2026-07-31 | URGN Feb avg: 3.12% median: 4.90% win: 50% σ: 13.59% n: 4 2022-04-12 → 2026-07-31 | URGN Mar avg: -7.17% median: -13.72% win: 25% σ: 16.43% n: 4 2022-04-12 → 2026-07-31 | URGN Apr avg: 8.94% median: 5.24% win: 60% σ: 19.42% n: 5 2022-04-12 → 2026-07-31 | URGN May avg: -17.70% median: -14.58% win: 20% σ: 30.14% n: 5 2022-04-12 → 2026-07-31 | URGN Jun avg: 67.72% median: 30.82% win: 100% σ: 88.62% n: 5 2022-04-12 → 2026-07-31 | URGN Jul avg: 29.21% median: 3.91% win: 60% σ: 48.07% n: 5 2022-04-12 → 2026-07-31 | URGN Aug avg: -9.42% median: -10.21% win: 25% σ: 9.75% n: 4 2022-04-12 → 2026-07-31 (current) | URGN Sep avg: -3.57% median: -3.06% win: 50% σ: 13.68% n: 4 2022-04-12 → 2026-07-31 | URGN Oct avg: 5.40% median: -0.43% win: 50% σ: 26.47% n: 4 2022-04-12 → 2026-07-31 | URGN Nov avg: 8.58% median: 10.63% win: 75% σ: 28.62% n: 4 2022-04-12 → 2026-07-31 | URGN Dec avg: -4.41% median: -6.32% win: 50% σ: 15.64% n: 4 2022-04-12 → 2026-07-31 |